$12.82 -0.14 (%) Insmed Inc - NASDAQ

Dec. 6, 2016 | 10:54 AM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Lung Disease Stocks Advance After Actelion Approached By J&J

    TalkMarkets | Nov. 25, 2016 | 17:04PM EST
  2. Markets Rise; Macy's Lowers Comparable Sales Outlook

    Benzinga | Aug. 13, 2014 | 09:59AM EST
  3. Benzinga's Volume Movers

    Benzinga | Aug. 13, 2014 | 09:31AM EST
  4. Dow Breaks Four Day Losing Streak As Calm Restores Last Week's Jittery Market

    Benzinga | Aug. 4, 2014 | 15:57PM EST
  5. Indexes Reverse Losses; Michael Kors Beats Expectations Again

    Benzinga | Aug. 4, 2014 | 14:13PM EST
  6. Alere Drops On Downbeat Results; Trex Shares Surge

    Benzinga | Aug. 4, 2014 | 12:03PM EST
  7. Markets Open Higher; Michael Kors Results Beat Street View

    Benzinga | Aug. 4, 2014 | 10:32AM EST
  8. Morning Market Losers

    Benzinga | Aug. 4, 2014 | 08:54AM EST
  9. Benzinga's Top #PreMarket Losers

    Benzinga | Aug. 4, 2014 | 07:16AM EST
  10. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga | Jun. 23, 2014 | 17:25PM EST
  11. Mid-Afternoon Market Update: Fed Tapers Another $10B; Will Purchase $15B/Month Of MBS & $20B Per Month Of Treasuries

    Benzinga | Jun. 18, 2014 | 14:39PM EST
  12. Mid-Day Market Update: US Stocks Slide Ahead Of Fed Decision; Adobe Shares Spike Higher

    Benzinga | Jun. 18, 2014 | 11:47AM EST
  13. Mid-Morning Market Update: Markets Mostly Flat; FedEx Results Top Street View

    Benzinga | Jun. 18, 2014 | 09:30AM EST
  14. Benzinga's Volume Movers

    Benzinga | Jun. 18, 2014 | 09:17AM EST
  15. Morning Market Movers

    Benzinga | Jun. 18, 2014 | 08:41AM EST
  16. Insmed Up Over 30% Following FDA Decision

    Benzinga | Jun. 18, 2014 | 07:24AM EST
  17. Benzinga's Top #PreMarket Gainers

    Benzinga | Jun. 18, 2014 | 07:05AM EST
  18. Insmed Shares Rally Over $14 As Piper Jaffray Boosts Price Target To $51

    Benzinga | Apr. 23, 2014 | 14:49PM EST
  19. Mid-Afternoon Market Update: American Capital Rises as MannKind Shares Take a Hit

    Benzinga | Mar. 31, 2014 | 15:03PM EST
  20. Mid-Day Market Update: Nordion Surges On Acquisition News; BlackBerry Shares Decline

    Benzinga | Mar. 31, 2014 | 11:20AM EST
  21. Insmed falls on mixed results

    IBD | Mar. 26, 2014 | 17:50PM EST
  22. Market Wrap For March 26: Markets Close Near Session Lows In Yet Another Volatile Trading Session

    Benzinga | Mar. 26, 2014 | 15:46PM EST
  23. Insmed Falls On Mixed Results For Lung Drug

    IBD | Mar. 26, 2014 | 11:18AM EST
  24. Morning Market Losers

    Benzinga | Mar. 26, 2014 | 08:53AM EST
  25. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 26, 2014 | 07:14AM EST
  26. UPDATE: Insmed Says Arikayce Did Not Meet Pre-Specified Level for Statistical Significance

    Benzinga | Mar. 26, 2014 | 06:17AM EST
  27. Benzinga's Top #PreMarket Gainers

    Benzinga | Feb. 18, 2014 | 08:08AM EST
  28. Benzinga's Top #PreMarket Losers

    Benzinga | Feb. 11, 2014 | 08:17AM EST
  29. UPDATE: Piper Jaffray Initiates Coverage on Insmed as 2014 Biotech Sector Outlook Remains Strong

    Benzinga | Nov. 27, 2013 | 10:48AM EST
  30. Market Wrap For Tuesday, October 15: Earnings Reports And White House Progress Send Markets Down

    Benzinga | Oct. 15, 2013 | 15:36PM EST
  31. Mid-Afternoon Market Update: Tumi Holdings Rises Amid Market Decline

    Benzinga | Oct. 15, 2013 | 14:30PM EST
  32. Insmed Reports Issuance of Two Patents

    Benzinga | Sep. 11, 2013 | 06:34AM EST
  33. Leerink Swann Reiterates Outperform on Insmed Following MEDACorp KOL Checks

    Benzinga | Aug. 28, 2013 | 10:52AM EST
  34. Weekly CEO Buys Highlight: TPGI, INSM, EQU, FCEL

    GuruFocus | Jan. 13, 2013 | 12:33PM EST
  35. Insmed Names Lewis CEO

    Benzinga | Sep. 11, 2012 | 01:08AM EST
  36. Insmed Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 7, 2012 | 04:19AM EST
  37. Insmed up 12% After Insider Share Purchase

    Benzinga | Jun. 15, 2012 | 07:10AM EST
  38. Insmed Provides Corporate Update; Projects Cash Sufficient to Generate Top-Line Data from Three Priority Studies

    Benzinga | May. 30, 2012 | 01:04AM EST
  39. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE In Patients With Non-tuberculous Mycobacterial Lung Disease

    Benzinga | May. 23, 2012 | 01:03AM EST
  40. Insmed Skyrockets 70% after FDA Lifts Clinical Hold

    Benzinga | May. 7, 2012 | 03:45AM EST
  41. Benzinga's Microcap Movers for Friday January 20, 2012

    Benzinga | Jan. 22, 2012 | 03:19AM EST
  42. Insmed Surges after Clinical Hold Lifted by FDA

    Benzinga | Jan. 20, 2012 | 02:06AM EST
Trading Center